SecBot SecBot
DEFA14A ·Filed Jun 23, 2026

LNSR

LENSAR, Inc.
NEUTRAL
Impact 2/10
Horizonweeks Processed4mo ago SEC0001193125-26-279544
Proxy solicitation materials
Actionable Insight • Neutral

Monitor for any dissident proxy filings or activist activity ahead of the August 4 meeting, given the recent CFO appointment and indications of a proxy contest. Stockholders should vote by August 3, 2026. No immediate trading catalyst from this filing alone.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
LNSR ▲ +17.00% at T+60d
NEUTRAL call +17.00% · α vs SPY +14.16% · entry $6.06 → $7.09
Entry = T+0 close
Jun 23, 2026
via day close
T+1d
+1.32%
call +1.32% · α +1.18%
$6.14
settled 4mo ago
T+5d
-3.63%
call -3.63% · α -5.34%
$5.84
settled 4mo ago
T+20d
-5.12%
call -5.12% · α -7.05%
$5.75
settled 3mo ago
T+60d
+17.00%
call +17.00% · α +14.16%
$7.09
settled 6w ago

Price Chart

Loading chart...

Executive Summary

LENSAR, Inc. filed definitive additional proxy materials (DEFA14A) providing notice of its 2026 Annual Meeting to be held virtually on August 4, 2026. The board recommends voting 'For' the election of three Class III director nominees, ratification of PricewaterhouseCoopers as auditor, approval of executive compensation on an advisory basis, and a frequency of one year for future say-on-pay votes. The filing is routine and does not contain material financial or operational updates.

Key Financial Metrics

Meeting
2026-08-04

Key Facts

  • Annual meeting scheduled for August 4, 2026, to be held virtually.
  • Record date for voting is June 10, 2026.
  • Board recommends 'For' all four proposals: director election, auditor ratification, say-on-pay, and frequency of say-on-pay.
  • This is a definitive additional proxy soliciting material (DEFA14A) filed by management.

Financial Impact

Not specified

Risk Factors

  • Potential activist campaign could lead to board changes or strategic shifts.
  • Recent CFO turnover may signal operational challenges.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-279544
Document: 0001193125-26-279544-index-headers.html0001193125-26-279544
Document: 0001193125-26-279544-index.html0001193125-26-279544
Document: 0001193125-26-279544.txt0001193125-26-279544
9 reports for LNSR
Performance horizon
80% Hit rate @ T+20 4 of 5 directional calls Went positive at some point 5 of 5 best @ T+20▲ +19.86%Sep 22, 2026
Filters
Rows
Reports for LNSR — sortable, filterable
TypeNow
Sep 22, 2026
5w ago
Institutional Cluster
BEARISH ★ 4/10
$7.25 $5.81▲ +19.86%▲ +19.30%$5.94 (+18.07%)
Aug 13, 2026
10w ago
8-K
BULLISH ★ 7/10
$8.27 $7.60▼ −8.10%▼ −6.35%$5.94 (−28.17%)
Jun 23, 2026
18w ago
DEFA14A
NEUTRAL ★ 2/10
$6.06 $5.75▼ −5.12%▼ −7.05%$5.94 (−1.98%)
May 12, 2026
24w ago
144
NEUTRAL ★ 2/10
$5.88 $5.68▼ −3.40%▼ −1.67%$5.94 (+1.02%)
May 8, 2026
24w ago
Press Release
BEARISH ★ 7/10
$5.64 $5.60▲ +0.71%▲ +0.73%$5.94 (−5.32%)
Apr 15, 2026
27w ago
8-K
BEARISH ★ 6/10
$5.80 $5.77▲ +0.52%▲ +6.33%$5.94 (−2.41%)
Mar 31, 2026
30w ago
8-K
BEARISH ★ 8/10
$5.96 $5.25▲ +11.91%▲ +21.34%$5.94 (+0.34%)
Mar 31, 2026
30w ago
Press Release
MIXED ★ 6/10
$5.96 $5.35▼ −10.23%▼ −19.66%$5.94 (−0.34%)
Mar 13, 2026
32w ago
8-K/A
NEUTRAL ★ 4/10
$9.85 $5.92▼ −39.90%▼ −43.49%$5.94 (−39.70%)
Showing 9 of 9

US Market Status

Market Closed — Opens Wed (15h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 23, 2026